Loading…
Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml Enoxaparin Sodium Injection USP 40mg/0.4ml

GENERIC NAME OF THE MEDICINAL PRODUCT:

Enoxaparin Sodium Injection USP 40mg/0.4ml

QUALITATIVE AND QUANTITATIVE COMPOSITION:

Enoxaparin Sodium Injection USP 40mg/0.4ml
Each 0.4ml contains:
Enoxaparin Sodium USP……………...40mg
Equivalent to 4,000 IU anti-Xa activity
Water for Injection BP……………. q.s. 0.4ml

THERAPEUTIC INDICATIONS:

Enoxaparin Sodium Injection USP is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism.

DIRECTION OF USE:

For Subcutaneous route, Intravascular route during hemodialysis.
Intramuscular Route Forbidden.
For Further information see enclosed package insert.

CAUTION & WARNING:

CAUTION: The injection should be discard if any visible particle appears.
Enoxaparin Sodium Starting material is porcine derived.
WARNING: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at or below 25°C.
Do not freeze pre-filled syringe.
Do not use later than the date of Expiry.
Keep all medicines out of reach of children.
Dosage: As directed by the Physician.

Enoxaparin Sodium Injection USP 40mg/0.4ml Technical Specification: 

Product Name:Enoxaparin Sodium Injection USP
(Low Molecular Weight Heparin)
Brand Name:Generic
Strength:40mg/0.4ml
Dosage Form:Liquid Injection
Packing:1 Ampoule & Sterile Syringe
Route of Administration:For Subcutaneous route, Intravascular route during hemodialysis. Do not Inject Intramuscularly.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Anti-Coagulant
Indication: Enoxaparin injection is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism.
Storage:Store at or below 25°C. Do not freeze pre-filled syringe. Do not use later than the date of Expiry.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Enoxaparin Sodium Injection USP 40mg/0.4ml

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Enoxaparin Sodium Injection USP 40mg/0.4ml
    Each 0.4ml contains:
    Enoxaparin Sodium USP………………40mg
    Equivalent to 4,000 IU anti-Xa activity
    Water for Injection BP……………. q.s.  0.4ml 

THERAPEUTIC INDICATIONS:

Enoxaparin Sodium Injection USP is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism.

DIRECTION OF USE:

For Subcutaneous route, Intravascular route during hemodialysis.

Intramuscular Route Forbidden.

For Further information see enclosed package insert.

CAUTION & WARNING:

CAUTION:  The injection should be discard if any visible particle appears.

Enoxaparin Sodium Starting material is porcine derived.

Warning:  Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage:  Store at or below 25°C.

Do not freeze pre-filled syringe.

Do not use later than the date of Expiry.

Keep all medicines out of reach of children.

Dosage:  As directed by the Physician.